Last Updated on March 10, 2025 by The Health Master
Drug recall
Glenmark Pharmaceuticals, you know, the big company from Mumbai, just made a drug recall of their ADHD drug, Atomoxetine, off shelves in the US.
We’re talking about almost one and a half million bottles, which is a lot.
Apparently, they found some stuff in it during their regular checks that shouldn’t be there.
What’s the problem?
Basically, they found a bit too much of something called N-Nitroso Atomoxetine.
Think of it like finding a tiny bit of dirt in your food, but a bit more serious.
The USFDA, that’s the Food and Drug Administration; they’re the ones who keep an eye on all this, said it’s because of “CGMP Deviations.”
That’s just fancy talk for saying they didn’t follow all the rules for making medicine properly.
Now, this N-Nitroso stuff, they’re still figuring out what it might do to people long-term.
Usually, there’s just a tiny bit, but when it’s too much, they have to act.
Which Pills Are Affected?
It’s Glenmark’s US branch, based in New Jersey, that’s handling the drug recall.
And it’s all different strengths of the Atomoxetine capsules, from the small 10 mg ones all the way up to the big 100 mg ones.
If you’re on this drug, you’ll want to pay attention.
- 10 mg
- 25 mg
- 40 mg
- 60 mg
- 80 mg
- 100 mg
How Serious Is This?
The USFDA considers this “Class II” drug recall.
That means it’s not like a life-threatening situation, but it still seriously matters.
They’re saying that it might cause some temporary problems, but the chances of anything really bad happening are pretty small.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Disclaimer: The information we have provided is for general knowledge and for informational purpose only and it cannot be treated as medical advice. Always consult your doctor for any health issues and / or for the treatment of the same. The Health Master does not claim responsibility for this information.
Karnataka’s new NSQ Drug Recall Policy
Drug recall: Glenmark and FDC recall Drugs due to this issue
Drug recall: Saline and critical drugs recalled in West Bengal
Drug recall: 1,394 batches of drugs recalled in 2023-24 due to quality issues
Karnataka’s new NSQ Drug Recall Policy
New Drug Approval: DCGI Demands Uniformity
FSSAI: Food Labelling and Display – Chapter-15
Workshop on NDPS to combat the misuse of drugs: FDA Haryana
No More Discount Boards at Pharmacies: Punjab
Call for National Drug Quality Alert System
USFDA issues warning letter to Jagsonpal Pharmaceuticals
NPPA revised retail price of 1 new formulation: February 2025
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
